Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,999
Total Claims
$936K
Drug Cost
811
Beneficiaries
$1,154
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-18%
Cost per patient vs peers
$1,154 vs $1,411 avg
+40%
Brand preference vs peers
14.9% vs 10.6% avg
Brand vs Generic
Brand: 1,476 claims · $574K
Generic: 8,433 claims · $357K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Omeprazole/Sodium Bicarbonate | 29 | $99K |
| Apixaban | 192 | $95K |
| Empagliflozin | 102 | $56K |
| Lipase/Protease/Amylase | 55 | $42K |
| Sitagliptin Phosphate | 59 | $32K |
| Sitagliptin Phos/Metformin Hcl | 39 | $22K |
| Linaclotide | 40 | $22K |
| Cyclosporine | 26 | $18K |
| Linagliptin | 45 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 85 | $16K |
| Rivaroxaban | 26 | $15K |
| Aripiprazole | 59 | $15K |
| Icosapent Ethyl | 41 | $12K |
| Insulin Aspart | 40 | $9,228 |
| Insulin Degludec | 13 | $8,515 |
Prescribing Profile
Patient Profile
82
Avg Age
66%
Female
2.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data